menu Search

Empowering Healthcare Decisions.
Right at the point of Care.

Search
Powered by AI - Try searching for:
special reports VIEW ALL
Antigen rapid tests: Moving toward more efficient COVID-19 testing
Infectious-Diseases Antigen rapid tests: Moving toward more efficient COVID-19 testing

At the time of writing, there have been 175,306,598 confirmed infections and 3,792,777 deaths attributed to the COVID-19 pandemic globally. [https://covid19.who.int/, accessed 14 June 2021] Real-time reverse transcription polymerase chain reaction (RT-PCR) has been instrumental in detecting the infection and preventing more widespread transmission of the disease.

16 Aug 2026 by Dr. Leong Hoe Nam
Infectious-Diseases PD TEST Long Text Test Data - Webcast: Covid-19: What it means to your clinic. Practice pearls for the Asian primary care physician.

Webcast: Covid-19: What it means to your clinic. Practice pearls for the Asian primary care physician.

31 Mar 2026
PD TEST Long Text Test Data - Webcast: Covid-19: What it means to your clinic. Practice pearls for the Asian primary care physician.
Gastroenterology Noninvasive diagnostic tests for NAFLD: Accuracy without the agony

Non-alcoholic fatty liver disease (NAFLD) is characterized by steatosis, liver cell injury and inflammation. It is rapidly becoming the most common liver disease worldwide. Its prevalence in Asia is increasing which is attributed to the increased metabolic risk factors including obesity, diabetes and metabolic syndrome. In a Sanofi-sponsored symposium during the Philippine Liver Meeting of The Hepatology Society of the Philippines at the EDSA Shangri-la Hotel, Mandaluyong City on 22 January 2020, Dr Jose Sollano Jr., Gastroenterologist at the Asian Hospital and Medical Center, explored the diagnostic approach to assess the severity of NAFLD and discussed the available noninvasive diagnostic tests to assess patients suspected with NAFLD.

31 Mar 2026
Noninvasive diagnostic tests for NAFLD: Accuracy without the agony
Multi-Specialty StrongHER, TogetHER: A comprehensive review of obstetrical dilemma in endometriosis and infertility

A comprehensive review of obstetrical dilemma in endometriosis and infertility  

16 Mar 2026
StrongHER, TogetHER: A comprehensive review of obstetrical dilemma in endometriosis and infertility
top medical news VIEW ALL
Product Highlights
Predzone_4C Predzone Contents : Prednisolone Indications/Uses : Variety of inflammatory diseases including severe asthma, RA, allergic reactions, severe skin conditions, & blood disorders. Appetite+OB_4C1 Appetite OB Contents : Fe sulfate monohydrate (equiv to 65.73 mg Fe) 200 mg, Na ascorbate [equiv to 100 mg ascorbic acid (vit C)] 112.49 mg, nicotinamide (vit B3) 20 mg, riboflavin phosphate [equiv to 2 mg riboflavin (vit B2)] 2.54 mg, thiamine mononitrate (vit B1) 2 mg, pyridoxine HCl (vit B6) 2 mg, folic acid (vit B9) 400 mcg, cyanocobalamin (vit B12) 10 mcg Indications/Uses : Prevention & treatment of vit C & B-complex, folic acid, & Fe deficiencies. Pre- & post-natal supplement. Sitazuca+&+Sitazuca+MH_4C Sitazuca Contents : Sitagliptin Indications/Uses : Type 2 DM in adults as monotherapy in patients inadequately controlled by diet & exercise alone & for whom metformin is inappropriate due to contraindications or intolerance; as dual oral therapy in combination w/ metformin when diet & exercise plus metformin alone do not provide adequate glycaemic control, w/ sulphonylurea when diet & exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control & when metformin is inappropriate due to contraindications or intolerance, or w/ peroxisome proliferator-activated receptor γ (PPARγ) agonist (ie, a thiazolidinedione) when use of a PPARγ agonist is appropriate & when diet & exercise plus the PPARγ agonist alone do not provide adequate glycaemic control; as triple oral therapy in combination w/ sulphonylurea & metformin when diet & exercise plus dual therapy w/ these medicinal products do not provide adequate glycaemic control, or w/ a PPARγ agonist & metformin when use of a PPARγ agonist is appropriate & when diet & exercise plus dual therapy w/ these medicinal products do not provide adequate glycaemic control. As add-on to insulin (w/ or w/o metformin) when diet & exercise plus stable dose of insulin do not provide adequate glycaemic control. Xylomet_4C1 Xylomet Contents : Xylometazoline HCl Indications/Uses : Symptomatic relief of nasal congestion due to common colds, upper resp allergies including hay fever & sinusitis. Cefudyne_4C1 Cefudyne Contents : Cefuroxime axetil Indications/Uses : FC tab: Infections in adults & childn ≥3 mth: Acute streptococcal tonsillitis & pharyngitis; acute bacterial sinusitis; acute otitis media; acute exacerbations of chronic bronchitis; cystitis; pyelonephritis; uncomplicated skin & soft tissue infections; early Lyme disease. Powd for oral susp: Bacterial infections eg, URTI (ENT infections, otitis media, sinusitis, tonsillitis, pharyngitis); lower resp tract infections (pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis); GUT infections (pyelonephritis, cystitis, urethritis); skin & soft tissue infections (furunculosis, pyoderma, impetigo); gonorrhea, acute uncomplicated gonococcal urethritis, cervicitis. Early Lyme disease & subsequent prevention of late Lyme disease. Neopred_4C1 Neopred Contents : Prednisolone Indications/Uses : Condition in which routine systemic corticosteroid therapy is indicated, except adrenocortical-deficiency states for which hydrocortisone w/ supplementary fludrocortisone is preferred. Xafariv_4C Xafariv 15/Xafariv 20 Contents : Rivaroxaban Indications/Uses : Treatment of DVT & pulmonary embolism (PE); prevention of recurrent DVT & PE in adults. Prevention of stroke & systemic embolism in adults w/ non-valvular atrial fibrillation w/ ≥1 risk factors (eg, CHF, HTN, age ≥75 yr, DM, prior stroke or transient ischaemic attack).
Drug Updates VIEW ALL
New Indication 1 new
Adcetris
New Presentation 1 new
Sterimar
New Brand 34 new
Acarva Show more →
New Dosage Strength 1 new
Natravox
Pill Identifier
Enter numbers or letters stamped on the pill (e.g., L484, M 30)...
Browse Drugs (A to Z)
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z #
#1 Medical Resource Since 1963

What is MIMS

For over 60 years, MIMS has served as Asia-Pacific region's leading clinical drug dictionary and medical decision-support platform, trusted by over 2.1 million healthcare professionals. MIMS delivers independent, evidence-based prescription drug monographs, multi-drug interaction checks, and localized regulatory guidelines designed to support confident decision-making at the point of care.
  • Clinical Independence
  • Evidence-based Data
  • Regulatory Alignment
Learn More About Us
Trusted by 2.1 million HCPs
17 Countries & Regions
Australia Malaysia Philippines Singapore Vietnam Thailand

Frequently Asked Questions

Absolutely. Our database is continuously updated by medical editors and references authoritative sources, ensuring accuracy and credibility.

Yes. You can access MIMS.com on desktop or mobile, and we also offer an app for on-the-go use.

Use the search bar located at the top of the homepage and enter either the brand name or generic name of the drug.

Go to "Diseases" and use the search bar located at the top of the page and enter the name of the disease.

Go to "Medical News & Updates" to access latest news and medical updates in MIMS.com
Explore More FAQs